These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 16276518)

  • 21. Prion protein interconversions.
    Caughey B
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):197-200; discussion 200-2. PubMed ID: 11260800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bad news and good news: what the dentist needs to know about transmissible spongiform encephalopathies.
    Gonzales TS; Rushing EJ
    Quintessence Int; 1998 May; 29(5):319-21. PubMed ID: 9693651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PrP genetics in ruminant transmissible spongiform encephalopathies.
    Goldmann W
    Vet Res; 2008; 39(4):30. PubMed ID: 18284908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of non-prion biomarkers for the diagnosis of Transmissible Spongiform Encephalopathies in the live animal.
    Parveen I; Moorby J; Allison G; Jackman R
    Vet Res; 2005; 36(5-6):665-83. PubMed ID: 16120244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retinal function and morphology are altered in cattle infected with the prion disease transmissible mink encephalopathy.
    Smith JD; Greenlee JJ; Hamir AN; Richt JA; Greenlee MH
    Vet Pathol; 2009 Sep; 46(5):810-8. PubMed ID: 19429980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The vagus nerve as a conduit for neuroinvasion, a diagnostic tool, and a therapeutic pathway for transmissible spongiform encephalopathies, including variant Creutzfeld Jacob disease.
    Pomfrett CJ; Glover DG; Pollard BJ
    Med Hypotheses; 2007; 68(6):1252-7. PubMed ID: 17166667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Introduction to the transmissible spongiform encephalopathies or prion diseases.
    Chesebro B
    Br Med Bull; 2003; 66():1-20. PubMed ID: 14522845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disease-specific particles without prion protein in prion diseases - phenomenon or epiphenomenon?
    Liberski PP; Brown P
    Neuropathol Appl Neurobiol; 2007 Aug; 33(4):395-7. PubMed ID: 17617871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current and future molecular diagnostics for prion diseases.
    Lehto MT; Peery HE; Cashman NR
    Expert Rev Mol Diagn; 2006 Jul; 6(4):597-611. PubMed ID: 16824033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Human transmissible spongiform encephalopathies].
    Leibovitz I; Zamir D; Polychuck I; Kahana E
    Harefuah; 2003 Jan; 142(1):70-3, 76. PubMed ID: 12647494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ecosystems supporting clusters of sporadic TSEs demonstrate excesses of the radical-generating divalent cation manganese and deficiencies of antioxidant co factors Cu, Se, Fe, Zn. Does a foreign cation substitution at prion protein's Cu domain initiate TSE?
    Purdey M
    Med Hypotheses; 2000 Feb; 54(2):278-306. PubMed ID: 10790765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prion diseases. Review of the literature on the light of two case reports of Creutzfeldt-Jakob disease].
    Skjaerpe KA; Tysnes OB; Mørk S
    Tidsskr Nor Laegeforen; 1996 Mar; 116(9):1081-5. PubMed ID: 8658476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prions, infections and confusions in the "transmissible" spongiform encephalopathies. The other evidence-based science. III. Review].
    León-S FE; Rodriguez CI; Prada DG
    Invest Clin; 2000 Sep; 41(3):189-210. PubMed ID: 11029835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The prion hypothesis and the human prion diseases].
    Aguzzi A
    Berl Munch Tierarztl Wochenschr; 2002; 115(3-4):91-8. PubMed ID: 11938572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The early history of the transmissible spongiform encephalopathies exemplified by scrapie.
    Schneider K; Fangerau H; Michaelsen B; Raab WH
    Brain Res Bull; 2008 Dec; 77(6):343-55. PubMed ID: 18951958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood infectivity, processing and screening tests in transmissible spongiform encephalopathy.
    Brown P
    Vox Sang; 2005 Aug; 89(2):63-70. PubMed ID: 16101685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transmissible spongiform encephalopathies (TSE): minimizing the risk of transmission by biological/biopharmaceutical products: an industry perspective.
    Kozak RW; Golker CF; Stadler P
    Dev Biol Stand; 1996; 88():257-64. PubMed ID: 9119148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostics for TSE agents.
    Raeber AJ; Oesch B
    Dev Biol (Basel); 2006; 123():313-23; discussion 349-54. PubMed ID: 16566455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metal microcrystal pollutants: the heat resistant, transmissible nucleating agents that initiate the pathogenesis of TSEs?
    Purdey M
    Med Hypotheses; 2005; 65(3):448-77. PubMed ID: 15908137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strain-specific viral properties of variant Creutzfeldt-Jakob disease (vCJD) are encoded by the agent and not by host prion protein.
    Manuelidis L; Liu Y; Mullins B
    J Cell Biochem; 2009 Feb; 106(2):220-31. PubMed ID: 19097123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.